This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Joseph Zeleznik
Advertisement
Joseph Zeleznik is manager, technical & regulatory affairs at Meggle USA.
Articles by Joseph Zeleznik
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
Advertisement
Latest Updated Articles
Mitigating the Risk from Excipient VariabilityPublished: August 3rd 2022 | Updated:
The Real Complexity of Excipient CompositionPublished: October 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
4
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
5
